Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients With Type 2 Diabetes: An Open-Label Study

BACKGROUND: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are novel agents used to treat type 2 diabetic patients. We investigated the efficacy of the SGLT2 inhibitor ipragliflozin on diabetic nephropathy in Japanese patients with type 2 diabetes. METHODS: A 50 mg dose of ipragliflozin was admin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Med Res
Hauptverfasser: Ito, Daisuke, Ikuma-Suwa, Emi, Inoue, Kazuyuki, Kaneko, Kimie, Yanagisawa, Morifumi, Inukai, Kouichi, Noda, Mitsuhiko, Shimada, Akira
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elmer Press 2017
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215019/
https://ncbi.nlm.nih.gov/pubmed/28090231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2875w
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge